6���l

5 ways to tell if you’re on track for retirement — and 5 things to do if you need to catch up, according to experts

Kerry Sirkka joins Medical Solutions as Chief Recruitment OfficerRutgers looks to pick up steam in clash vs. Seton Hall

Rutgers looks to pick up steam in clash vs. Seton HallCaitlin Clark honored as AP Female Athlete of the Year following her impact on women's sports Caitlin Clark has been named the AP Female Athlete of the Year after raising the profile of women’s basketball to unprecedented levels in both college and the WNBA. She led Iowa to the national championship game, was the top pick in the WNBA draft and captured rookie of the year honors in the league. Fans packed sold-out arenas and millions of television viewers followed her journey on and off the court. Clark's exploits also put other women's sports leagues in the spotlight. A group of 74 sports journalists from AP and its members voted on the award. Other athletes who received votes included Olympic gold medalist Simone Biles and boxer Imane Khelif. Clark’s only the fourth women’s basketball player to win the award since it was first given in 1931. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

5 ways to tell if you’re on track for retirement — and 5 things to do if you need to catch up, according to experts(Updated at 10:38 a.m. ET/ 1538 GMT) By Ragini Mathur and Nikhil Sharma Dec 12 (Reuters) - Canada's main stock index dropped to a more-than-two-week low on Thursday, dragged by commodity stocks, as investors grew nervous about the domestic economic growth amid looming tariff threats by Donald Trump. The Toronto Stock Exchange's S&P/TSX composite index was down 209.55 points, or 0.82%, at 25,448.45, and was trading at its lowest since Oct. 31. At least nine sectors on the index nursed losses, led by the commodity-focussed sectors, with materials falling 2.1%, tracking gold and copper prices. The heavyweight energy also declined 2% as oil prices decreased following forecasts of ample supply, which offset the optimism around a potential U.S. interest rate cut. The Canadian central bank slashed its key policy rate by 50 basis points on Wednesday to help boost the country's slower growth. "This is the fifth consecutive rate cut and another super-sized cut as well" and "signals a weaker-than-expected economy in Canada," said Shiraz Ahmed, senior portfolio manager and founder of Sartorial Wealth at Raymond James. "Adding to this are the ongoing tariff discussions," Ahmed continued, which he said are among the factors that are "creating a sense of unease in the markets". Trump's tariff threats have raised fears of a trade war between the U.S. and Canada, with the majority of Canadian oil exports sent across the border. Among individual stocks, Empire Company jumped 7.6% to scale to an all-time high after the food and retail distribution company surpassed estimates for second-quarter profit. Imperial Oil fell 4.8% following its forecast of higher crude production in 2025, as the Canadian energy major expects to ramp up output from existing oil sands assets. Stateside, producer prices rose more than anticipated in November, while weekly jobless claims unexpectedly rose last week. (Reporting by Ragini Mathur; Editing by Vijay Kishore)

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Dec 12, 2024-- Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq Capital Market the Company will voluntarily delist its common shares from the Canadian Securities Exchange. The shares will be delisted from the Canadian Securities Exchange at the close of trading on December 17, 2024. The Company’s common shares will continue to trade on the Nasdaq under the symbol “ACOG”. About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (“mTBI”), for which there are currently no approved treatment options. ZUNVEYL is a patented drug approved as a new generation acetylcholinesterase inhibitor (AChEI) for the treatment of Alzheimer’s disease, with expected minimal gastrointestinal side effects. ZUNVEYL’s active metabolite is differentiated from donepezil and rivastigmine in that it improves the function of neuronal nicotinic receptors, most notably the alpha-7 subtype, which is known to have a positive effect on cognition. Benzgalantamine is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. Forward-looking Statements: This news release includes forward-looking statements within the meaning of applicable securities laws. Except for statements of historical fact, any information contained in this news release may be a forward‐looking statement that reflects the Company’s current views about future events and are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although the Company believes to have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. The Company cannot assure that the actual results will be consistent with these forward-looking statements. These forward‐looking statements speak only as of the date of this news release and the Company undertakes no obligation to revise or update any forward‐looking statements for any reason, even if new information becomes available in the future. View source version on businesswire.com : https://www.businesswire.com/news/home/20241212186439/en/ CONTACT: For further information: Michael McFadden, CEO Tel: 1-858-344-4375 info@alphacognition.com KEYWORD: TEXAS UNITED STATES NORTH AMERICA CANADA INDUSTRY KEYWORD: BIOTECHNOLOGY NEUROLOGY HEALTH PHARMACEUTICAL HEALTH TECHNOLOGY SOURCE: Alpha Cognition Inc. Copyright Business Wire 2024. PUB: 12/12/2024 06:41 PM/DISC: 12/12/2024 06:42 PM http://www.businesswire.com/news/home/20241212186439/enPublished 3:41 pm Friday, December 13, 2024 By Staff Reports Here’s a peek at the injury report for the Minnesota Wild (19-6-4), which currently has five players listed, as the Wild prepare for their matchup against the Philadelphia Flyers (14-12-4) at Xcel Energy Center on Saturday, December 14 at 2:00 PM ET. Place your bets on any NHL matchup at BetMGM. Sign up today using our link. Watch 1,000+ out-of-market NHL games, ESPN+ Hockey Night & more streaming all season on ESPN+. Catch NHL action all season long on Fubo. Catch NHL action all season long on Max. Bet on this or any NHL matchup at BetMGM. Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER .5 ways to tell if you’re on track for retirement — and 5 things to do if you need to catch up, according to experts

LOS ANGELES , Dec. 24, 2024 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions company, today announced that its Board of Directors has declared the following cash dividend on the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock"). Holders of Series A Preferred Stock will receive a cash dividend equal to $560.00 per whole share. Holders of depositary shares, each representing a 1/1000 fractional interest in a share of Series A Preferred Stock (Nasdaq: CDZIP), will receive a cash dividend equal to $0.56 per depositary share. The dividend will be paid on January 15, 2025 , to applicable holders of record as of the close of business on January 3, 2025 . About Cadiz, Inc. Founded in 1983, Cadiz, Inc. (NASDAQ: CDZI) is a California water solutions company dedicated to providing access to clean, reliable and affordable water for people through a unique combination of water supply, storage, pipeline and treatment solutions. With 45,000 acres of land in California , 2.5 million acre-feet of water supply, 220 miles of pipeline assets and the most cost-effective water treatment filtration technology in the industry, Cadiz offers a full suite of solutions to address the impacts of climate change on clean water access. For more information, please visit https://www.cadizinc.com . Safe Harbor Statement This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "anticipates", "expect", "may", "plan", or "will". Forward-looking statements include, without limitation, projections, predictions, expectations, or beliefs about future events or results and are not statements of historical fact, including statements regarding the Company's expectations regarding payments of dividends in the future. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements. These and other risks are identified in our filings with the Securities and Exchange Commission (the "Commission"), including without limitation our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Reports on Form 10-Q and other filings subsequently made by the Company with the Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise. View original content to download multimedia: https://www.prnewswire.com/news-releases/cadiz-inc-declares-quarterly-dividend-for-q4-2024-on-series-a-cumulative-perpetual-preferred-stock-302339009.html SOURCE Cadiz, Inc.